MEBIS, Jeroen

Email Alert RSS Feed

Profile

Full Name
MEBIS, Jeroen
Email
jeroen.mebis@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 71-87 of 87 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
712015Evaluation of the effect of low level laser therapy on oral mucositis in breast cancer patients: a retrospective analysisMEBIS, Jeroen; Censabella, S.; MAES, Annelies; Noé, L.; BULENS, PaulConference MaterialC2
722014LOW LEVEL LASER THERAPY FOR THE MANAGEMENT OF RADIATION DERMATITIS: PRELIMINARY RESULTS OF A PILOT STUDY IN BREAST CANCER PATIENTSCENSABELLA, S.; ROBIJNS, Jolien; CLAES, S.; BULENS, Paul; MEBIS, JeroenJournal ContributionM
732014Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapyBatair, A.; Van Fraeyenhoven, F.; Vandebroek, A.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
742013Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case reportVan Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen; MEBIS, JeroenJournal ContributionA2
752013Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancerBaitar, A.; van Fraeyenhove, F.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
762013‘Screening cancer patients distress and care needs: translation and validation of the Cancer Rehabilitation Evaluation System (CARES) for the Flemish population in Belgium.’SCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; MEBIS, Jeroen; Vandenborre, Katherine; HELLINGS, JohanConference MaterialC2
772012Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment).Wolter, Pascal; Hendrickx, Tine; Renard, Vincent; MEBIS, Jeroen; Debruyne, Philip R.; Wynendaele, Wim; Schallier, Denis C. C.; Vermeij, Joanna; Nielander, Aldrik; Machiels, Jean-Pascal H.; Rottey, Sylvie; Delande, Stephanie; Goeminne, Jean-Charles; Schoffski, Patrick; De Coster, Sandra; Lacour, Valerie; Foulon, VeerleJournal ContributionM
782012Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST TrialLlombart, Antonio; Frassoldati, Antonio; Paija, Outi; Sleeboom, Harm Peter; Jerusalem, Guy; MEBIS, Jeroen; Deleu, Ines; Miller, Joel; Schenk, Nora; Neven, PatrickJournal ContributionA1
92012Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
102012METABOLIC PHENOTYPE BY NMR SPECTROSCOPY: A BIOMARKER FOR LUNG CANCERLOUIS, Evelyne; REEKMANS, Gunter; BAETEN, Kurt; MESOTTEN, Liesbet; THOMEER, Michiel; VANHOVE, Karolien; MEBIS, Jeroen; Vandeurzen, Kurt; Darquennes, Karen; ADRIAENSENS, PeterConference MaterialC2
112012The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years laterVanderhaegen, J.; Paridaens, R.; Piccart, M.; Lalami, Y.; Machiels, J.P.; Jerusalem, G.; Borms, M.; Goemine, J.; MEBIS, Jeroen; Dirix, L.; Lintermans, A.; Brouckaert, O.; Neven, P.Conference MaterialC2
122012Will ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events?MEBIS, JeroenConference MaterialC2
132011Metabolic phenotyping by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
142010Melanoma incidence trends in Limburg after screening and prevention campaignsVanstraelen, D.; Deleu, H.; VAN ROBAYS, Johan; DHollander, D.; CLOES, Edith; Lousberg, D.; Kuijpers, G.; ADRIAENS, Brecht; MEBIS, Jeroen; Mathei, Catharina; Buntinx, F.Journal ContributionA2
152010Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematological malignancy after antibiotic change: a single centre prospective study with 15 years of follow-upMEBIS, Jeroen; Jansens, Hilde; AYELE, Girma; MOLENBERGHS, Geert; Schroyens, W.; Gadisseur, Alain; Van de Velde, An L. R.; Vrelust, Inge; Goossens, Herman; Berneman, Zwi N.Journal ContributionA1
162005Pseudo-thrombopenie. Een niet altijd even goed gekend laboartoriumfenomeen.De Greef, Y.; Claeys, R.; MEBIS, Jeroen; Janssen, M.; Vanstraelen, D.; Madoe, V.; RUMMENS, Jean-Luc; Bries, G.Journal ContributionA1
172005Oncologische revalidatie : een stap voorwaarts in een kwaliteitsvolle zorg van de kankerpatiëntDe Greef, Y.; DENDALE, Paul; CLAES, Guido; Vanstraelen, D.; Madoe, V.; Bries, G.; MAES, Annelies; Brosens, M.; BULENS, Paul; MEBIS, JeroenJournal ContributionA1
show all